
Glucometrics provides an AI-based system that automates intensive insulin therapy and customizes diabetes care. Its core is an Intensive Insulin Therapy API built on CGM data and medical-expertise-driven algorithms. The company sells APIs, performs technology transfer, and collaborates with medical device makers on CGM and insulin pumps. Focused on Asia, it adapts its technology to regional lifestyles to compete with Western peers.

Glucometrics provides an AI-based system that automates intensive insulin therapy and customizes diabetes care. Its core is an Intensive Insulin Therapy API built on CGM data and medical-expertise-driven algorithms. The company sells APIs, performs technology transfer, and collaborates with medical device makers on CGM and insulin pumps. Focused on Asia, it adapts its technology to regional lifestyles to compete with Western peers.